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Andrew J. Dwork,4,5,6,7 James E. Goldman,5 Adrianus C. M. Boon,2 Maura Boldrini4,6
and Robyn S. Klein1,2,8,9

Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with acute and post
acute cognitive and neuropsychiatric symptoms including impaired memory, concentration, attention, sleep and af
fect. Mechanisms underlying these brain symptoms remain understudied. Here we report that SARS-CoV-2-infected
hamsters exhibit a lack of viral neuroinvasion despite aberrant blood–brain barrier permeability. Hamsters and
patients deceased from coronavirus disease 2019 (COVID-19) also exhibit microglial activation and expression of
interleukin (IL)-1β and IL-6, especially within the hippocampus and the medulla oblongata, when compared
with non-COVID control hamsters and humans who died from other infections, cardiovascular disease, uraemia
or trauma. In the hippocampal dentate gyrus of both COVID-19 hamsters and humans, we observed fewer neuro
blasts and immature neurons. Protracted inflammation, blood–brain barrier disruption and microglia activation
may result in altered neurotransmission, neurogenesis and neuronal damage, explaining neuropsychiatric presenta
tions of COVID-19. The involvement of the hippocampus may explain learning, memory and executive dysfunctions
in COVID-19 patients.
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Abbreviations: BBB = blood–brain barrier; COVID-19 = SARS-CoV-2 disease; dpi = days post-infection; GCL = granule cell
layer; IONinferior olivary nuclei; NeuN = neuronal nuclear marker; OB = olfactory bulb; ONE = olfactory
neuroepithelium; SARS-CoV-2 = severe acute respiratory syndrome beta-coronavirus; SGZ = subgranular zone

Mounting evidence indicates that infection with severe acute re
spiratory syndrome beta-coronavirus (SARS-CoV-2) leads to newonset neuropsychiatric symptoms. During SARS-CoV-2 disease
(COVID-19), patients without prior neuropsychiatric history can
present with difficulty concentrating, insomnia, fatigue, hallucina

neuroinflammation and neuronal damage, resulting in altered
neurotransmission and brain function.

Materials and methods
All data generated or analysed during this study are included in this
published article and its Supplementary material files.

tions, delusions and behavioural changes, including suicide.1,2
Patients hospitalized in the intensive care unit (ICU) have been re
ported to show agitation (69%) and corticospinal tract signs (67%)
indicative of encephalopathy, and at discharge some patients represent with a dysexecutive syndrome (33%).3
A number of recent studies show that postacute sequelae of
COVID-19 (PASC) at 2 months after discharge include a variety
of neuropsychiatric symptoms, including impaired immediate
verbal memory and learning, delayed verbal memory, verbal fluency,
working memory, anxiety, depression and posttraumatic stress dis
order (PTSD) symptoms.1 These symptoms persisted for at least
1 year.4 The neurobiological bases of these symptoms are unknown.
In COVID-19 decedents, our group and others reported postmortem neuropathological findings of hypoxia, microglial activa
tion, astrogliosis, a mild lymphocytic infiltration and micro and
macro haemorrhages, despite finding no detectable viral RNA or
protein in CNS tissue.5,6
In this study, we focused on three areas of the brain, the cortex,
hippocampus, medulla and olfactory bulb (OB). In addition to its
role in memory, the hippocampus is involved in executive func
tions, processing speed, path integration and spatial processing,7
and thus hippocampal damage might play some role in PASC symp
toms. Neuroimaging studies in postacute COVID-19 patients show
disruption of fractional anisotropy and diffusivity, suggesting
microstructural and functional alterations of the hippocampus.8
These hippocampal functions have been shown to depend on adult
hippocampal neurogenesis.9 Importantly, two of the cytokines
found elevated in COVID brains, IL-1β and IL-6, have antineurogenic
effects in the hippocampus. The medulla appears to be an area of
pronounced microglial activation in COVID-19 brains, and contains
nuclei regulating autonomic nervous system activity, conscious
ness and motor coordination. The OB has garnered attention in
COVID-19 because of its neuronal link to the olfactory neuroepithe
lium, where virus has been detected.10
To investigate pathologies in more detail, we investigated CNS
changes associated with SARS-CoV-2 infection in Golden Syrian
hamsters, validating our findings in humans deceased from severe
COVID-19, compared with uninfected hamsters and age- and sexmatched humans (Supplementary Table 1). The Golden Syrian
hamster (Mesocricetus auratus) exhibits pathogenesis and transmis
sibility of SARS-CoV-2 similar to that observed in humans, with
upper and lower respiratory symptoms and pathological signs.11,12
We analysed infected hamster and human OB, cortex medulla,
and hippocampus, and report increased blood–brain barrier (BBB)
permeability, microglial activation, microglial and neuronal ex
pression of IL-1β and IL-6, respectively, and reduced hippocampal
neurogenesis compared with uninfected controls. These studies
support the notion that COVID-19 cytokine storm may induce

Results
Hamsters intranasally infected with SARS-CoV-2 do
not exhibit viral neuroinvasion
The Golden Syrian hamster is naturally susceptible to SARS-CoV-2
infection. Intranasal inoculation results in mild-to-moderate dis
ease with laboured breathing, ruffled fur, weight loss and hunched
posture.12 To examine the utility of the hamster model in defining
neuroinflammatory and vasculature alterations that could result
in memory, executive function and emotional dysregulation during
and after COVID-19, we evaluated olfactory neuroepithelial and
brain tissue from 5–6-week-old male hamsters infected intranasally
(i.n.) with 2 × 105 plaque forming units (PFU) of a fully infectious
SARS-CoV-2 isolate (strain 2019-nCov/USA-WA1/20202) during
acute infection and at 7 days after recovery. Whole heads of unin
fected and infected hamsters were collected throughout the acute
infectious period and at 1 week after viral clearance, which occurs
in the lungs at 5–7 days post-infection (dpi).11 High levels of
SARS-CoV-2 RNA was detected within the hamster ethmothurbi
nates at 2–4 dpi, and completely cleared by 8 dpi (Fig. 1A and B). As
previously reported,13 viral RNA was detected within K18+ sustenta
cular cells of the olfactory neuroepithelium (ONE) (Fig. 1C), which
might impact olfactory sensory neuron function via loss of calcium
signalling.14 SARS-CoV-2-infected sustentacular cells exhibited de
creased expression of K18+ compared with uninfected ONE
(Supplementary Video 1) and were found sloughed off into the nasal
cavities of infected hamsters (Supplementary Video 2). No viral RNA
was detectable in the acute and recovered hamster OB, cortex,
hippocampus or medulla oblongata at any time point post-infection
(Supplementary Fig. 1A).

Hamster and human SARS-CoV-2 infection is
associated with widespread BBB disruption
Multiple reports show BBB dysfunction in patients with
COVID-19.15,16 To evaluate effects of SARS-CoV-2 on BBB integrity
in the hamster model, we assessed brain levels of extravasated ser
um IgG via immunohistochemistry. At 3–4 dpi there was a signifi
cant increase in IgG+ pixels, indicative of BBB disruption, in the
OB, cortex, hippocampus and medulla oblongata, but the hippo
campus suffered the most significant changes compare to naïve
hamsters (Fig. 1D–F and Supplementary Fig. 2). In the medulla
oblongata BBB disruption increased from early time points to
5 dpi (Fig. 1E and F, middle). Similar persistent alterations in IgG im
munoreactivity were observed in the OB and cortex, albeit to a
lesser degree when compared to the hippocampus or medulla
(Supplementary Fig. 2A and B).
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We next examined BBB permeability in human COVID-19 brain
tissue samples via detection of fibrinogen, a blood coagulation
protein whose CNS deposition is implicated in a wide range of
neurological disease and injuries associated with BBB disruption.17
In a subset of COVID-19 decedents (n = 7) compared with age- and
sex-matched controls (Supplementary Table 1) deceased from
other infections (n = 3) or cardiovascular disease (n = 2), we observed
increased fibrinogen in the hippocampus (Fig. 1G, right and H, right)
and a smaller, but significant, increase in medulla (Fig. 1G, left and

H, left) and OB (Supplementary Fig. 2C). Together, these data sug
gest that SARS-CoV-2 infection may lead to region-specific altera
tions in human BBB integrity.

Hamster SARS-CoV-2 infection results in microglia
activation and increased brain cytokines
Interferon (IFN) γ and IL-6 are well-known for altering BBB perme
ability18 and have been detected in high levels in the serum of
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Figure 1 SARS-CoV2 infects hamster ONE and induces BBB disruption in hamsters and patients with COVID-19. (A) In situ hybridization for viral RNA at
2 dpi revealed SARS-CoV2 consistently targeted the ethmoturbinates of hamsters, with no infection of the CNS parenchyma. (B) Representative images
of viral SARS-CoV2 mRNA in the hamster ethmoturbinates at naïve, 2, 3, 4, 5, 8 and 14 dpi. (C) Co-localization of viral RNA (red) via in situ hybridization
and immunodetection of K18+ sustenticular cells (green) of the ONE in naïve or SARS-CoV2-infected hamsters at 7 dpi. Nuclei counterstained with DAPI
(blue). (D) Representative image of blood–brain permeability in the hamster brain 2 dpi, showing staining for IgG (green) and DAPI (blue).
(E) Representative images of IgG detection (green) within hamster MO and hippocampi at naïve, 2, 3, 4, 5, 8 and 14 dpi, and nuclear stain, DAPI
(blue), followed by (F) quantitation of IgG intensity in the total CNS parenchyma (white outline) (top, Overview), medulla (middle, Medulla), and hippo
campus (bottom, Hippocampus) at all time points. (G) Representative image of blood–brain permeability in the medulla (left) and hippocampus (right) of
control and COVID-19 patient tissue, depicting detection of fibrinogen (green) and DAPI (blue). (H) Quantification of fibrinogen intensity in control ver
sus COVID-19 patient tissues derived from medulla (top) and hippocampus (bottom). Data were pooled from at least two independent experiments.
Scale bars = 50 μm (×10), 20 μm (×20) or 10 μm (×63). Data represent the mean ± SEM and were analysed by two-way ANOVA or Student’s t-test.
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Figure 2 Microglia contribute to neuroinflammation in the medulla oblongata and hippocamus of SARS-CoV-2-infected hamsters. Representative
images of IBA1 in the hamster inferior olivary nuclei (ION) (A) and hippocampus (D) at naïve, 2, 3, 4, 5, 8 and 14 dpi, showing staining for IBA1 (red)
and DAPI (blue) at ×20 and ×63. Immunostaining for IL-1β and IBA1 in the hamster ION (B) and hippocampi (E) at naïve, 2, 3, 4, 5, 8 and 14 dpi, presented
as microscopy with IBA1 (red), IL-1β (green) and DAPI (blue). Quantitation of per cent IBA1+ and IL-1β+ areas, and IL-1β+IBA1+ area, normalized to total
IL-1B+ area for ION (C) and hamster (F). Data were pooled from at least two independent experiments. Scale bars = 20 μm (×20) or 10 μm (×63). Data
represent the mean ± SEM and were analysed by two-way ANOVA or Student’s t-test.
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Figure 3 Microglia and neurons contribute to neuroinflammation in the medulla and hippocampus of COVID-19 patients. Representative image of IBA1 in
control and COVID-19 patient ION (A, top) and hippocampus (A, bottom), showing staining for IBA1 (magenta) and DAPI (blue) at ×20 and ×63, and quantified
for per cent IBA1+ area (C and D, left). Immunostaining for IL-1β and IBA1 in ION and hippocampus of control and COVID-19 patients, presented
(Continued)
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Human COVID-19 patients exhibit microglial and
neuronal expression of interleukins
In order to validate our findings in SARS-CoV-2-infected hamsters
in human COVID-19 patients, we evaluated microglial activation
and cytokine expression in CNS tissues derived from a subset of

COVID-19 decedents with CNS inflammatory changes but without
neurologic disease,5 using the same methods as described above
[Supplementary Table 1, COVID-19 decedents (n = 7) and age- and
sex-matched non-COVID-19 controls (n = 5, Supplementary Table 1,
Group A)]. As in hamsters, examination of SARS-CoV-2 RNA within
the OB, cortex and hippocampus via in situ hybridization did not re
veal infection (Supplementary Fig. 1B). However, COVID-19 postmortem inferior olivary nuclei of the medulla revealed significant
microglial activation and increased IL-1β expression, compared
with control subjects (Fig. 3A, top, B and C). Elevated expression of
IL-6 was also detected in neurons of the inferior olivary nuclei
(Fig. 3G, top and H). Similar to hamsters, hippocampal tissue from
COVID-19 patients exhibited significantly increased IBA1+ cell num
bers and co-localization of IBA1 with IL-1β (Fig. 3A, bottom, B and
D) and of NeuN with IL-6 expression (Fig. 3G, bottom and I) compared
with control subjects. Hippocampal tissues in non-COVID patients
exhibited robust immunodetection of doublecortin (DCX)+/IBA1−
and DCX+/glial fibrillary acidic protein (GFAP)− cells (Fig. 3E and F).
OB tissue exhibited elevated expression of IL-1β in IBA1+ micro
glia, with microglial activation (Supplementary Fig. 4C) compared
with uninfected controls. Moreover, OB from COVID-19 patients ex
hibited elevated neuronal expression of IL-6 compared with con
trols (Supplementary Fig. 4D).
We also examined whether astrocytes exhibited activate in
brain tissues from COVID-19 patients using a GFAP antibody, as
done above for hamsters. In COVID-19 human tissue samples,
GFAP+ immunostaining was increased in the medulla but not the
OB or hippocampus, compared to controls, and significant increases
in IL-1β levels in GFAP+ astrocytes were observed in the OB of
COVID-19 patients when compared to controls (Supplementary
Fig. 6). No differences in astrocytes IL-1β immunostaining were
observed between COVID-19 and control patients in the hippocam
pus and medulla oblongata (Supplementary Fig. 6). Taken together,
these results validate findings observed in the CNS of
SARS-CoV-2-infected mice in humans with COVID-19.

Loss of hippocampal neurogenesis in hamsters and
humans infected with SARS-CoV-2
Because adult neurogenesis may be affected by inflammation,21 we
hypothesized the cytokine surge following SARS-CoV-2 infection
might affect adult neurogenesis. In rodents, adult hippocampal
neurogenesis is a robust and well-established phenomenon,22
and IL-1β inhibits neurogenesis during viral encephalitis, both
acutely and after recovery,23 and IL-6 represses neurogenesis
through DNA demethylation/methylation.24 Unfortunately, there
are no commercially available antibodies to detect IL-6 in hamster
tissues. However, consistent with the detected increase in IL-1β in
the hippocampus of SARS-CoV-2-infected hamsters, we observed
a gradual decline in number of cells expressing Ki67, a marker of
proliferation, and DCX, a marker of neuroblasts and immature neu
rons, as well as DCX+/Ki67+ cells, that were almost completely
absent in the subgranular zone (SGZ) at 5 dpi (Fig. 4A and C).

Figure 3 Continued
as microscopy with IBA1 (magenta), IL-1β (green) and DAPI (blue) (B) and per cent IL-1β+ area and IL-1β+IBA1+ area, normalized to total IBA1+ areas for
both regions (C and D, middle and right). (E) Representative images of IBA1 in the human adult hippocampus with high-magnification images single
channel. Sections stained with DAPI (blue), IBA1 (green) and DCX (red) in non-COVID-19 control. Scale bar = 25 μm. (F) Representative images of
GFAP in the human adult hippocampus with high-magnification images single channel. Sections stained with DAPI (blue), GFAP (green) and DCX
(red) in non-COVID-19 control. The arrow points to a single DCX+/GFAP− neuron in the subgranular zone (SGZ). Scale bar = 25 μm. Immunostaining
for IL-6 and NeuN in ION and hippocampus of control and COVID-19 patients, presented as microscopy with NeuN (red), IL-6 (green) and DAPI
(blue) (G) and per cent IL-6+ area and IL-16+NeuN+ area, normalized to total NeuN+ area (H and I). Data were pooled from at least two independent ex
periments. Scale bars = 20 μm (×20) or 10 μm (×63). Data represent the mean ± SEM and were analysed by two-way ANOVA or Student’s t-test.
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SARS-CoV-2-infected hamsters.19 Given that loss of BBB integrity
may permit CNS entrance of cytokines or immune cells, we exam
ined cytokine expression by glia and neurons and microglia activa
tion in the same brain regions via immunofluorescence. For
cytokine expression studies, we co-localized expression of ionized
calcium-binding adapter molecule 1 (IBA1), a marker of microglia,
and neuronal nuclear marker (NeuN), a marker of neurons, with
IL-1β and IL-6 in hamster and human brain tissue.
Medulla oblongata from SARS-CoV-2-infected hamsters showed
increased levels of IBA1 at 4 dpi, which remained elevated at 14 dpi
(Fig. 2A and C, left). Consistent with the increased expression of
IBA1, activated microglia were observed, displaying larger cell bod
ies and thicker processes than those detected in brain tissue from
uninfected animals. This finding was particularly pronounced
within the inferior olivary nuclei (ION), a region that coordinate sig
nals from the spinal cord to the cerebellum, regulating motor co
ordination and learning via integration of glutamatergic synaptic
inputs.20 IBA1+ activated microglia of SARS-CoV-2-infected ham
sters within the ION exhibited increased expression of IL-1β at 2–
5 dpi compared to uninfected hamsters, which returned to baseline
by 8 dpi (Fig. 2B and C, middle and right). Hippocampal
SARS-CoV-2-hamster tissue similarly revealed a gradual increase
in IBA1+ activated microglia versus uninfected hamsters, peaking
at 5 dpi (Fig. 2D and F, left), and IL-1β levels increased at 2 dpi, peak
ing at 5 dpi before gradually decreasing to naïve levels by 14 dpi
(Fig. 2E and F, middle and right).
We also examined the OB and cortex of SARS-CoV-2-infected
hamsters (2–5 dpi), which exhibited elevated microglial activation
(Supplementary Fig. 3A, B and D) and, in the OB, expression of
IL-1β within IBA1+ microglia (Supplementary Fig. 4A and B, top)
compared to control tissue. In hamster somatosensory cortex, colocalization of IL-1β within IBA1+ microglia was not significantly
elevated (Supplementary Fig. 4B, bottom).
To determine whether astrocytes contribute to neuroinflamma
tion in the CNS of infected hamster, using a SOX9 antibody, we ob
served no changes in astrocyte cell numbers in OB, medulla and
hippocampus of infected hamsters compared to naïve animals
(Supplementary Fig. 5). These data suggest that, while astrocytes
may be involved in post-infection neuroinflammation in the OB, a
region proximal to the location of viral replication, microglia appear
to be the main players in more remote brain regions, like the me
dulla and hippocampus. Taken altogether, our findings show that,
despite lack of viral neuroinvasion, SARS-CoV-2-infected indivi
duals develop microglial activation and cytokine expression in
brain regions associated with olfactory function, motor coordin
ation, memory and learning.
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To determine whether this effect was region-specific, we per
formed similar analysis of the rostral migratory stream, which dis
played no change in DCX+/Ki67+ cell numbers in infected hamsters
compared to uninfected controls (Supplementary Fig. 7).
Next, we compared numbers of DCX+ neuroblast and DCX+/
NeuN+ immature neurons in the SGZ and granule cell layer (GCL)

from another subset of COVID-19 decedents who succumbed to
pneumonia or stroke (n = 17) and age- and sex-matched
non-COVID-19 controls (n = 8, Supplementary Table 1, Group B).
Because DCX+ cells migrate from the SGZ into the GCL as they ma
ture and start expressing NeuN,25 DCX+/NeuN− cells in the SGZ are
more likely neuroblasts and DCX+/NeuN+ cells located in the GCL
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Figure 4 Neuroblast proliferation in the SARS-CoV2 infected hamster and doublecortin (DCX)-positive cells and neurons in human hippocampus from
COVID-19 patient and non-COVID-19 control. (A) Microscopy of the dentate gyrus of hamsters at naïve, 2, 3, 4, 5, 8 and 14 dpi, showing staining of Ki67
(red), neuroblast (green) and DAPI (blue), followed by quantification of per cent Ki67+DCX+ cells, normalized to the total number of DCX+ cells.
(C) Quantification of per cent DCX+Ki67+ area, normalized to total DCX+ area in the rostral migratory stream of hamsters at naïve, 2, 3, 4, 5, 8 and
14 dpi. Data were pooled from at least two independent experiments. Scale bars = 50 μm. Data represent the mean ± SEM and were analysed by twoway ANOVA. (B) Select images of whole hippocampus and high-magnification images sections stained with DAPI (blue), NeuN (green) and DCX (red)
from COVID-19 patient and non-COVID-19 control. The granule cell layer (GCL), subgranular zone (SGZ) and molecular layer (ML) of the dentate gyrus
are visible, combined channels imaged at ×20; scale bar = 500 μm. High-magnification images were captured at ×63, scale bar = 20 μm. (D) In the SGZ,
DCX+/NeuN− cells were fewer in COVID-19 patients versus controls [P = 0.026; t(7.794) = 2.731; Welch’s t-test for non-stoichiometric data], with no group
differences in DCX+/NeuN+ cell number (P = 0.189; Mann–Whitney). In the GCL, neither DCX+/NeuN− cell count (P = 0.846; Mann–Whitney) nor DCX+/
NeuN+ cell count (P = 0.378; Mann–Whitney) differs between COVID-19 and control subjects. Per cent of DCX+/NeuN− cells located in the SGZ versus
the GCL did not differ between control and COVID-19 groups (P = 0.453; Mann–Whitney). Per cent of DCX+/NeuN+ cells located in the GCL versus the
SGZ was lower in COVID-19 patients versus control subjects (P = 0.009; Mann–Whitney).
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Discussion
This study identifies potential neurobiological mechanisms of CNS
damage in SARS-CoV-2 infection, involving BBB disruption, elevated
levels of interleukins and blunted hippocampal neurogenesis. Loss
of hippocampal neurogenesis may contribute to cognitive and emo
tional symptoms observed in COVID-19 patients, involving deficits
of verbal memory and learning, working memory and executive func
tions, set-shifting, attention, anxiety, depression and PTSD symp
toms.1,4 Limitations of this study include the small sample sizes,
and the lack of reagents for detecting additional inflammatory factors
in hamsters. Moreover, hamsters develop milder disease without
hypoxia, which is different from humans who died from COVID-19.
Cytokines may be the main mediator of BBB disruption and cel
lular damage as levels in hamsters were highest in areas with more
significant BBB disruption. IL-1β, which is elevated in the CSF of
COVID-19 patients,27 destabilized the BBB,28 and loss of BBB integ
rity may permit entrance of cytokines and immune cells into the
brain, which, in turn, may activate glial cells. Neural progenitor
cell IL-1β receptors have been implicated in reducing neurogenesis
in murine models of flavivirus encephalitis.21,23 Fewer DCX+/NeuN−
neuroblasts in the SGZ of COVID-19 patients compared with
non-COVID-19 controls suggests either decreased progenitor cell
maturation or increased neuroblast death.
The time course of human pathological findings remains un
known, and if similar to hamsters, one would expect that after the
initial cytokine surge, neurogenesis might recover, as cognitive
symptoms and anosmia subside in many patients. Nevertheless,
long COVID symptoms have been widely reported. There is the pos
sibility that, in some individuals, the neurogenic niche might not
have enough multipotent progenitors for neurogenesis to resume
after this insult, as the multipotent progenitor pool is smaller in
aging humans.26 If this was the case, some patients might not be
able to recover and COVID-19 may result in chronic neuropsychi
atric symptoms, as observed in several clinical studies.1,4
Moreover, the hypoxia that results from the severe pulmonary dis
ease of these patients has been associated with activation of micro
glia in the absence of viral infection, and can also affect DCX+ cells.29
Brain alterations were transient in hamsters, peaking after viral
clearance in the nasal cavity. In humans, we do not know how long
elevated inflammatory markers persist in subjects who survive the
disease. The persistence of neuropsychiatric symptoms in long
COVID cases suggests that neuronal damage may be prolonged.
Brain imaging studies investigating inflammation markers in

post-COVID patients are warranted. Studies using PET radiotracers
for the brain translocator protein (TSPO)30 located on microglia and
astroglia may reveal useful for gathering data on indices of brain in
flammation levels in post-COVID patients.
Given the likely predominant role of neuroinflammation in the
mechanism of brain damage in COVID-19, anti-IL-6 and anti-IL-1β
therapies, currently under investigation,31 could be useful in limit
ing a prolonged cytokine storm, possibly preventing motor, cogni
tive, neurovegetative and emotional dysfunctions.
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